Viewing StudyNCT06614192



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06614192
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-25

Brief Title: A Randomized Trial Assessing Adverse Events and Disease Activity When Comparing Intravenously IV Infused ABBV-400 to Trifluridine and Tipiracil LONSURF Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Over-Expressed Refractory Metastatic Colorectal Cancer
Sponsor:
Organization: None